Investment Summary |
|
|---|---|
| Date | 2021-02-16 |
| Target | Zomentum |
| Sector | Software |
| Investor(s) | Eight Roads |
| Deal Type | Venture |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 1969 |
| PE ASSETS | 11.0B USD |
| Size | Mega |
| Type | Sector Focused |
Eight Roads is a private investment firm focused on a variety of investment opportunities across the US, Europe, and Asia. The Firm is divided into several investment strategies including venture, principal investing, and real estate. Within the principal investments group, Eight Roads backs established growth businesses with long-term capital. Eight Roads does not have any sector preferences, but has experience in fintech, business services, and healthcare. Eight Roads is based in London.
| DEAL STATS | # |
|---|---|
| Overall | 243 of 293 |
| Sector: Software M&A | 35 of 46 |
| Type: Venture M&A Deals | 220 of 266 |
| State: Delaware M&A | 1 of 2 |
| Country: United States M&A | 105 of 120 |
| Year: 2021 M&A | 3 of 29 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-02-09 |
Notonthehighstreet
Surrey, United Kingdom Notonthehighstreet is an operator of a curated modern marketplace connecting the small creative businesses with the world. Bringing together 3.6million customers with more than 5000 small creative businesses selling more than 250,000 products, notonthehighstreet offers a curated product selection with unique designs, high-quality craftsmanship, and inspiring stories about the people who make them - while providing small businesses across the UK with an engaged customer base, expert business support, and ready-made tech and data infrastructure. Notonthehighstreet was founded in 2006 and is based in Surrey, United Kingdom. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-03-08 |
Westlake Therapeutics
Hangzhou, China Westlake Therapeutics develops a variety of innovative cell therapy products for rare diseases, cancer, immunity and metabolism and other major diseases, which are characterized by strong substitutability and high safety. Westlake Therapeutics is based in Hangzhou, China. |
Buy | - |